Analysis of prognostic factors for patients with leiomyoma treated with uterine arterial embolization.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 17997392.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of the study was to describe a clinically useful factors index predicting long-term efficacy of uterine artery embolization (UAE). Newly diagnosed patients with uterine leiomyoma wishing to retain their uterus underwent UAE at our institution. Clinical demographics and 4 prognostic factors were recovered from the medical record. A regrowth-free interval (RFI) was calculated for all patients based on leiomyoma regrowth or recurrence of any previously reported symptoms. RFI by prognostic factor was analyzed by the Kaplan-Meier method. Forty-three patients were identified. Two prognostic factors were identified by multivariate analysis: vascularity (dichotomized as hypervascular vs hypovascular; RFI at 2 years, 80% vs 20%, P = .001) and number of nodules (solitary vs multiple; RFI at 2 years, 72% vs 25% at 2 years, P = .001) UAE success may be predicted by 2 preoperative parameters. Further investigation is warranted.
Medical subject headings
- Arteries
- Embolization, Therapeutic
- Leiomyoma
- Uterine Neoplasms
- Uterus